Optimizing Drug Delivery to the Brain for Breast Metastasis: A Novel Method for Tumor Targeting

Area of Science:

• Neuro-oncology
• Drug Delivery Systems
• Biomedical Engineering

Background:

• Brain metastases pose treatment challenges due to the blood-brain barrier.
• Intraventricular drug delivery for intra-axial pathologies remains underexplored.
• Prior research indicated preferential drug accumulation in breast cancer tissue via hyperosmolar intraventricular delivery.

Purpose of the Study:

• To investigate molecular parameters optimizing intraventricular drug delivery to intra-axial brain metastases.
• To test the hypothesis that low molecular weight drugs in high osmolarity solutions enhance tumor delivery.

Main Methods:

• Utilized an intracerebral breast cancer tumor model in nude rats.
• Examined iron-labeled dextran molecules of varying sizes (3, 5, 10 kD) and delivery solution osmolarities (307, 353, 368 mOsm/L).
• Analyzed dextran distribution using 7T MRI and confirmed with histopathology post-sacrifice.

Main Results:

• MRI quantification correlated well with histopathology findings.
• Smaller dextran molecules achieved earlier peak tumor concentrations, while larger molecules showed prolonged retention.
• Optimal preferential accumulation of 10 kD dextran in tumor tissue was observed, except at 368 mOsm/L.

Conclusions:

• Hyperosmolar intraventricular delivery shows promise for targeted drug delivery to brain tumors.
• Optimizing molecular weight and osmolarity is crucial for effective drug distribution to intra-axial brain metastases.